Voluntary disclosure announcement on initiation of phase III clinical trial of adsorbed tetanus vaccine and completion of enrollment of the first patient

SZSI · Mar 21

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.